Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides

Nonabsorbable disaccharides have been the mainstay of treatment for hepatic encephalopathy since introduced into clinical practice in 1966. Their beneficial effects reflect their ability to reduce the intestinal production/absorption of ammonia. A recent Cochrane review confirmed the efficacy and sa...

Descripción completa

Detalles Bibliográficos
Autor principal: Morgan, Marsha Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145904/
https://www.ncbi.nlm.nih.gov/pubmed/27638474
http://dx.doi.org/10.1007/s11011-016-9910-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145904/
https://www.ncbi.nlm.nih.gov/pubmed/27638474
http://dx.doi.org/10.1007/s11011-016-9910-2

Ejemplares similares